Enhancing involvement of people with multiple sclerosis in clinical trial design

Gray, Emma, Amjad, Anneesa, Robertson, Jenny, Beveridge, Judy, Scott, Susan, Peryer, Guy ORCID: https://orcid.org/0000-0003-0425-6911, Braisher, Marie, Pugh, Cheryl, Peres, Sara, Marrie, Ruth Ann, Sormani, Maria Pia and Chataway, Jeremy (2023) Enhancing involvement of people with multiple sclerosis in clinical trial design. Multiple Sclerosis Journal, 29 (9). pp. 1162-1173. ISSN 1352-4585

[thumbnail of gray-et-al-2023-enhancing-involvement-of-people-with-multiple-sclerosis-in-clinical-trial-design]
Preview
PDF (gray-et-al-2023-enhancing-involvement-of-people-with-multiple-sclerosis-in-clinical-trial-design) - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (372kB) | Preview

Abstract

Background: Although often overlooked, patient and public involvement (PPI) is vital when considering the design and delivery of complex and adaptive clinical trial designs for chronic health conditions such as multiple sclerosis (MS). Methods: We conducted a rapid review to assess current status of PPI in the design and conduct of clinical trials in MS over the last 5 years. We provide a case study describing PPI in the development of a platform clinical trial in progressive MS. Results: We identified only eight unique clinical trials that described PPI as part of articles or protocols; nearly, all were linked with funders who encourage or mandate PPI in health research. The OCTOPUS trial was co-designed with people affected by MS. They were central to every aspect from forming part of a governance group shaping the direction and strategy, to the working groups for treatment selection, trial design and delivery. They led the PPI strategy which enabled a more accessible, acceptable and inclusive design. Conclusion: Active, meaningful PPI in clinical trial design increases the quality and relevance of studies and the likelihood of impact for the patient community. We offer recommendations for enhancing PPI in future MS clinical trials.

Item Type: Article
Uncontrolled Keywords: multiple sclerosis,clinical trials,engagement,involvement,patient and public involvement,neurology,clinical neurology ,/dk/atira/pure/subjectarea/asjc/2800/2808
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Faculty of Medicine and Health Sciences > School of Health Sciences
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Centres > Institute for Volunteering Research
Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 18 Aug 2023 13:31
Last Modified: 19 Oct 2023 03:34
URI: https://ueaeprints.uea.ac.uk/id/eprint/92884
DOI: 10.1177/13524585231189678

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item